ARK Kraaifontein PMTCT trial

计划入组 0 人

Invest-CTO PCI Trial

计划入组 200 人 · 首次发布于 2021 年 3 月 1 日

Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST)

计划入组 26 人 · 首次发布于 2021 年 11 月 10 日

ARK-E021

99mTc-Ark

VDO-52

ARK INVESTMENTS (AUST) PTY LTD

Australia

Ark Therapeutics Ltd.

United Kingdom

Shanghai Ark Biopharmaceutical Co., Ltd.

China

Ark Invest Exits BioNTech Position Amid Revenue Decline and Leadership Transition

Intellia Therapeutics Gains Momentum as ARK Invest and Institutional Investors Back CRISPR Gene Editing Platform

Recursion Pharmaceuticals' AI-Discovered Drug REC-4881 Shows Promise in Phase 1b/2 FAP Trial